CompoAtlas

GlutaClear

GlutaClear, licence 80049046: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
NAC-2 Plex 2.0
Licence holder
Metagenics Inc.
NPN or DIN-HM
80049046
Status
Active licence
Licence date
7 March 2014
Revision date
23 December 2015
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
3-Pyridinecarboxamide375.0 mgNot calculated
Brassica oleracea var. italica

Source : Graine(s)

Extract : Matériel brut sec

Extraction ratio : 20.0:1.0

Dry plant equivalent : 385.0 mg

Potency : 2.5 mg Glucoraphanin

19.25 mgNot calculated
Sélénium

Source : Selemethionine

37.5 mcg75 µg

Non-medicinal ingredients

Hypromellose, Hydroxypropylcellulose, Dioxyde de silicium, Triglycérides à chaîne moyenne, Acide stéarique, Cellulose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19.0 Année(s)2.0 Comprimé1.0 Jour(s)

Uses authorised in Canada

To provide antioxidants for the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps normal growth and development. N-acetyl-L-Cysteine is a potent antioxidant for the maintenance of good health in individuals under oxidative stress. Supports the immune system in adults over 65 years of age and in those suffering from chronic degenerative diseases. To help relieve symptoms of chronic bronchitis. A supportive therapy in the treatment of inflammation of the respiratory systems. Mycolytic agent. For the maintenance of a strong immune system.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80049046

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2015. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2015. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line